Sort
82,697 grants matching “vaccine development”
PA-50/PA-41 antitoxin antibody therapy for C. difficile infection
$1,128,535William C Olson · Progenics Pharmaceuticals, Inc. · R01 · FY2012 · AI
Novel Technologies to Isolate and Analyze Extrachromosomal DNAs for Diagnostic Applications
$1,128,400Massa J. Shoura · Phinomics Inc. · R44 · FY2024 · GM
VACCINATION AGAINST INTRAPARTUM HIV CLADE C TRANSMISSION
$1,128,280Dana-Farber Cancer Institute · P01 · FY2000 · AI
Optimizing combination therapy for Hepatitis C virus with pharmacodynamic models
$1,127,672Ashley Brown · University Of Florida · R01 · FY2015 · AI
University of California, San Diego Clinical Trial Unit
$1,127,587Stephen A Spector · University Of California, San Diego · U01 · FY2008 · AI
Units for HIV/AIDS Clinical Trials Networks
$1,127,203Ram Yogev · Lurie Children'S Hospital Of Chicago · U01 · FY2011 · AI
NIH Tetramer Core Facility
$1,127,149John Altman · Emory University · N01 · FY2024 · AI
Molecular approaches to understand vector-host and vector-pathogen interactions
$1,126,987Jesus Valenzuela · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
$1,126,946Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI
Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses
$1,126,946Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · R01 · FY2022 · AI
Production of Pedigreed SPF Rhesus Macaques
$1,126,856Jeffrey A Roberts · University Of California At Davis · U42 · FY2017 · OD
International Training in AIDS-Related Epidemiology
$1,126,827Harvard University (Sch Of Public Hlth) · D43 · FY2005 · TW
COMBINED VACCINE STRATEGIES FOR THE PREVENTION OF AIDS
$1,126,760Therion Biologics Corporation · P01 · FY2003 · AI
Project 3: Anti-HIV/SHIV Efficacy of Combination Antiretroviral Intravaginal Ring
$1,126,561Richard B Pyles · Oak Crest Institute Of Science · U19 · FY2018 · AI
Modeling human hepatotropic infections in complex tissue organoids
$1,126,288Charles M. Rice · Rockefeller University · R01 · FY2010 · DK
IND Enabling Studies for Small Molecule Anthrax Lethal Factor Inhibitors
$1,126,264Alan Thomas Johnson · Hawaii Biotech, Inc. · R01 · FY2013 · AI
Immunobiology of Influenza Virus-related Critical Illness in Young Hosts
$1,126,202Adrienne G Randolph · Boston Children'S Hospital · R01 · FY2024 · AI
Using DNA/MVA/protein immunization of rhesus macaques to investigate how the background of the HIV-1 envelope and nature of the protein boost shape the genetic and functional antibody landscape.
$1,126,153Cynthia Ann Derdeyn · Emory University · R01 · FY2019 · AI
MHC-bound, SIV-derived, CTL and HTL Epitopes
$1,125,888David I Watkins · University Of Wisconsin-Madison · R24 · FY2010 · RR
CONTROLLED RELEASE POLYMERS FOR BRAIN TUMORS (U19 CA 528
$1,125,634Johns Hopkins University · U19 · FY2001 · CA
Computational and Experimental RNA Nanobiology
$1,125,500Bruce Shapiro · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Chiang Mai University HIV/AIDS Clinical Trials Unit
$1,125,479Thira Sirisanthana · Chiang Mai University · U01 · FY2011 · AI
Integrase
$1,125,242Stephen H Hughes · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
HUMAN IMMUNE RESPONSES TO HPV VACCINES
$1,125,221Johns Hopkins University · P01 · FY2002 · AI
MECHANISMS OF IMMUNOPATHOLOGY IN DHF/DSS
$1,125,215Univ Of Massachusetts Med Sch Worcester · P01 · FY2000 · AI